Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials
Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic Antimalarials is a NA clinical asset sponsored by Fondation Ophtalmologique Adolphe de Rothschild in Toxicity, Drug, Maculopathy. SEO and diligence focus: spectral domain optical coherence tomography C-scan and multifocal electroretinogram, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Toxicity, Drug
Modality: medical device
Target: spectral domain optical coherence tomography C-scan and multifocal electroretinogram
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 24, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: spectral domain optical coherence tomography C-scan and multifocal electroretinogram
View original source fields
Condition raw: Toxicity, Drug, Maculopathy
Condition normalized: Toxicity, Drug, Maculopathy
Modality raw: medical device
Modality normalized: medical device
Target raw: spectral domain optical coherence tomography C-scan and multifocal electroretinogram
Target normalized: spectral domain optical coherence tomography C-scan and multifocal electroretinogram